Literature DB >> 32220624

Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis.

Jing Luo1, Chengfei Yang1, Xing Luo1, Yang Yang1, Jia Li1, Bo Song1, Jiang Zhao1, Longkun Li2.   

Abstract

AIMS: This study aimed to investigate the therapeutic effect and molecular mechanism of chlorogenic acid (CGA) on cyclophosphamide (CYP)-induced rat interstitial cystitis (IC).
MATERIALS AND METHODS: An animal model of IC was established by intraperitoneal injection of CYP in female Sprague-Dawley rats. Eighty rats were randomly assigned to four groups: negative control (NC), NC treated with CGA (NC + CGA), IC, and IC treated with CGA (IC + CGA). Bladder urination function was assessed by analyzing urodynamic parameters. The expression of apoptosis-related proteins and inflammatory biomarkers in bladder specimens was detected using western blot and immunohistochemistry analysis. KEY
FINDINGS: Compared with the IC group, bladder urinary function was significantly improved in the IC + CGA group. CGA treatment reduced inflammatory damage in the bladder tissue of IC rats. Caspase3 and Bax expression was higher while Bcl-2 expression was lower in the IC group compared to the IC + CGA group. In addition, there were significant differences between the groups in the expression levels of inflammatory biomarkers in the bladder tissue. Furthermore, CGA could inhibit CYP-induced MAPK/NF-κB phosphorylation in the rat bladder tissue. SIGNIFICANCE: In a CYP-induced rat model of IC, CGA could reduce inflammation and apoptosis, thus partially restoring bladder function, and the MAPK/NF-κB pathway was probably involved in it.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chlorogenic acid; Interstitial cystitis; MAPK/NF-κB

Year:  2020        PMID: 32220624     DOI: 10.1016/j.lfs.2020.117590

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Laura Brandolini; Andrea Aramini; Gianluca Bianchini; Anna Ruocco; Riccardo Bertini; Rubina Novelli; Patrizia Angelico; Anna Elisa Valsecchi; Roberto Russo; Vanessa Castelli; Annamaria Cimini; Marcello Allegretti
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

2.  The Isopropyl Gallate Counteracts Cyclophosphamide-Induced Hemorrhagic Cystitis in Mice.

Authors:  Lucas Solyano Almeida de Oliveira; Sara Raquel de Moura Bandeira; Rodrigo Lopes Gomes Gonçalves; Benedito Pereira de Sousa Neto; Diana Carvalho de Rezende; Antonio Carlos Dos Reis-Filho; Ian Jhemes Oliveira Sousa; Flaviano Ribeiro Pinheiro-Neto; Boris Timah Acha; Gabriela do Nascimento Caldas Trindade; Lázaro Gomes do Nascimento; Damião Pergentino de Sousa; Fernanda Regina de Castro Almeida; Massimo Lucarini; Alessandra Durazzo; Daniel Dias Rufino Arcanjo; Francisco de Assis Oliveira
Journal:  Biology (Basel)       Date:  2022-05-09

3.  Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization.

Authors:  Hengshuai Zhang; Xingyou Dong; Zhenxing Yang; Jiang Zhao; Qudong Lu; Jingzhen Zhu; Longkun Li; Shanhong Yi; Jie Xu
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

4.  Adenosine A2A Receptor Agonist Polydeoxyribonucleotide Alleviates Interstitial Cystitis-Induced Voiding Dysfunction by Suppressing Inflammation and Apoptosis in Rats.

Authors:  Il-Gyu Ko; Jun-Jang Jin; Lakkyong Hwang; Sang-Hoon Kim; Chang-Ju Kim; Kyu Yeoun Won; Yong Gil Na; Khae Hawn Kim; Su Jin Kim
Journal:  J Inflamm Res       Date:  2021-02-15

5.  Protective effect of Aster tataricus extract on NLRP3-mediated pyroptosis of bladder urothelial cells.

Authors:  Xin Wang; Ling Fan; Hao Yin; Yiqun Zhou; Xiaolong Tang; Xiaojun Fei; Hailin Tang; Juan Peng; Xiaoqin Ren; Yi Xue; Chunli Zhu; Jianping Luo; Qinglei Jin; Qingjiang Jin
Journal:  J Cell Mol Med       Date:  2020-10-08       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.